Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Pharma deals during March 2013

Pharma deals during March 2013 At the end of February, the FDA approved Abilify Maintena (aripiprazole), an intramuscular extended-release depot formulation for the treatment of schizophrenia and the first commercialised product to evolve from this ... injectable in 14 European

Otsuka licenses Lundbeck’s Alzheimer's drug in $825m deal

Otsuka licenses Lundbeck’s Alzheimer's drug in $825m deal Abilify Maintena (aripiprazole) in the US.

Otsuka and Lundbeck extend CNS collaboration

Otsuka and Lundbeck extend CNS collaboration Follows US approval of depot antipsychotic Abilify Maintena. Otsuka and Lundbeck have revised and extended their central nervous system (CNS) alliance in the wake of last week's approval of depot ... formulations of Abilify that are currently being

Depot Abilify approval in US buoys Lundbeck and Otsuka

Depot Abilify approval in US buoys Lundbeck and Otsuka Abilify Maintena (aripiprazole) – for which Lundbeck has partnered with Japanese pharma company Otsuka in the US - becomes the first depot formulation of a dopamine D2 partial agonist to be cleared by ... Abilify Maintena was turned down by the FDA

Former Nycomed CEO Hakan Bjorklund to chair Lundbeck

Former Nycomed CEO Hakan Bjorklund to chair Lundbeck The company could secure US approval for a long-acting depot formulation of its Otsuka-partnered schizophrenia drug Abilify (aripiprazole) by the end of this month, but the highlight in the

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics